← Back to Search

Other

[14C]-TNP-2092 for Healthy Subjects

Phase 1
Waitlist Available
Research Sponsored by TenNor Therapeutics Limited
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Negative serology results for hepatitis B surface antigen (HBsAg), hepatitis C virus antibody (HCV Ab), and human immunodeficiency virus antibody (HIV Ab)
Non-smoker (with no use of other tobacco or nicotine containing products, in any form), as documented by history (no nicotine within 6 months prior to Screening) and a negative cotinine test at Screening and Admission See Section 5.3 for details of nicotine and tobacco restrictions
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 7
Awards & highlights

Study Summary

This study is evaluating whether a single dose of a radioactive drug can be safely given to healthy people.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 7
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 7 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mass balance of TNP-2092 and the percentages of radiolabel recovered in urine and feces
Pharmacokinetics (PK) of TNP-2092 in plasma
Secondary outcome measures
Routes and rates of elimination of [14C] TNP 2092

Trial Design

1Treatment groups
Experimental Treatment
Group I: [14C]-TNP-2092Experimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
[14C]-TNP-2092
2021
Completed Phase 1
~10

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

TenNor Therapeutics LimitedLead Sponsor
2 Previous Clinical Trials
133 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby Mar 2025